DILANTIN phenytoin sodium 100 mg capsule bottle Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

dilantin phenytoin sodium 100 mg capsule bottle

viatris pty ltd - phenytoin sodium, quantity: 100 mg - capsule, hard - excipient ingredients: gelatin; magnesium stearate; erythrosine; purified talc; titanium dioxide; sunset yellow fcf; carbon black; lactose monohydrate; maize starch; sucrose - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration).

DILATIN  phenytoin sodium 30 mg capsule bottle Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

dilatin phenytoin sodium 30 mg capsule bottle

viatris pty ltd - phenytoin sodium, quantity: 30 mg - capsule, hard - excipient ingredients: magnesium stearate; purified talc; gelatin; carbon black; titanium dioxide; lactose monohydrate; maize starch; sucrose - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration).

PONSTAN mefenamic acid 250mg capsule blister pack Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

ponstan mefenamic acid 250mg capsule blister pack

pfizer australia pty ltd - mefenamic acid, quantity: 250 mg - capsule, hard - excipient ingredients: gelatin; carbon black; iron oxide yellow; brilliant blue fcf; lactose monohydrate; titanium dioxide - treatment of primary dysmenorrhoea and primary menorrhoea. short-term relief of mild to moderate pain such as dental pain and soft tissue pain.

Pulse Co-oximeter probe, reusable Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pulse co-oximeter probe, reusable

masimo australia pty ltd - 47582 - pulse co-oximeter probe, reusable - a photoelectric component of a pulse co-oximeter that is applied externally to a body part (e.g., a fingertip for adults, the hand or foot for neonates), for the transcutaneous multiwave measurement of carboxy-haemoglobin saturation (spco) and typically several other related parameters such as arterial oxygen saturation (spo2), methaemoglobin saturation (spmet), haemoglobin concentration (sphb), haematocrit, and pulse rate using light detection. the device is re usable.

Pulse Co-oximeter probe, reusable Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pulse co-oximeter probe, reusable

draeger australia pty ltd - 47582 - pulse co-oximeter probe, reusable - the rainbow reusable sensors are intended for "spot check" or continuous non-invasive monitoring of arterial saturation (spo2), arterial carboxyhemoglobin saturation (spco) and other related parameters including arterial methemoglobin (spmet), and pulse rate when used with draeger patient monitors.

Pulse Co-oximeter probe, single-use Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pulse co-oximeter probe, single-use

masimo australia pty ltd - 47581 - pulse co-oximeter probe, single-use - a photoelectric component of a pulse co-oximeter that is applied externally to a body part (e.g., a fingertip for adults, the hand or foot for neonates), for the transcutaneous multiwave measurement of carboxy-haemoglobin saturation (spco) and typically several other related parameters such as arterial oxygen saturation (spo2), methaemoglobin saturation (spmet), haemoglobin concentration (sphb), haematocrit, and pulse rate using light detection.the device is single use.

Pulse Co-oximeter probe, single-use Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pulse co-oximeter probe, single-use

draeger australia pty ltd - 47581 - pulse co-oximeter probe, single-use - the rainbow sensors are intended for the continuous non-invasive measurement and monitoring of carboxy hemoglobin saturation (spco) and several other related parameters including arterial oxygen saturation (spo2), methemoglobin saturation (spmet), haemoglobin concentration (sphb) and pulse rate, when used with draeger patient monitors. the device is single use.

Parkell's Digitest - Stimulator, electrical, dental pulp testing Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

parkell's digitest - stimulator, electrical, dental pulp testing

henry schein halas - 13187 - stimulator, electrical, dental pulp testing - this powered device helps determine the vitality of the dental pulp, hence is indicated for use on vital and non-vital adult human dentition.

Pulse Co-oximeter Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pulse co-oximeter

masimo australia pty ltd - 46201 - pulse co-oximeter - the device is indicated for the continuous non-invasive monitoring of functional oxygen saturation of arterial haemoglobin (spo2), pulse rate, carboxyhemoglobin saturation, methemoglobin saturation, total haemoglobin concentration, and/or respiratory rate.; and is indicated for use with adult, paediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, and mobile environments. the device has an additional mode to provide clinicians with a guided tool to help screen newborns for critical congenital heart disease (cchd) per the established cchd screening protocol.